Pathios Therapeutics Limited

Pathios Therapeutics is a biotech company developing first-in-class cancer therapies. Their approach focuses on inhibiting GPR65, a novel target linked to immunologically-mediated diseases, to counteract immunosuppression in the tumor microenvironment. This leads to a novel immuno-oncology approach.

Buy Funded Startups lists

Funding Round: Series B

Funding Amount: $25M

Date: 18-Apr-2024

Investors: Bristol Myers Squibb, Canaan, Brandon Capital

Markets: Biotech, Immuno-Oncology

HQ: Oxford, Oxfordshire, United Kingdom

Founded: 2017

Website: https://www.pathios.com/

LinkedIn: https://uk.linkedin.com/company/pathios-therapeutics-limited

Twitter:

Instagram: